BackgroundIn 2020, South Korea’s National Health Insurance (NHI) began reimbursing individually prescribed herbal medicine decoctions (HMDs) for dysmenorrhea, highlighting the need for robust post-cov
Supplemental material of historical-prospective real-life cohort study on the impact of first-line medical therapy for amiodarone-induced thyrotoxicosis on cardiovascular events and hospitalizations
